Noelle Marie Cocoros, D.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Influenza, Human | 15 | 2024 | 1518 | 3.440 |
Why?
|
Product Surveillance, Postmarketing | 4 | 2021 | 452 | 1.270 |
Why?
|
United States Food and Drug Administration | 12 | 2022 | 1661 | 1.240 |
Why?
|
Respiratory Tract Infections | 2 | 2024 | 1009 | 1.030 |
Why?
|
Electronic Health Records | 14 | 2024 | 4803 | 0.980 |
Why?
|
Lyme Disease | 3 | 2024 | 631 | 0.850 |
Why?
|
Influenza A Virus, H1N1 Subtype | 4 | 2021 | 445 | 0.830 |
Why?
|
Drug Utilization | 2 | 2019 | 1186 | 0.820 |
Why?
|
Pneumonia, Ventilator-Associated | 4 | 2021 | 279 | 0.800 |
Why?
|
Algorithms | 9 | 2024 | 14018 | 0.800 |
Why?
|
Public Health Informatics | 2 | 2020 | 109 | 0.790 |
Why?
|
Research Design | 4 | 2023 | 6174 | 0.780 |
Why?
|
Drug Prescriptions | 5 | 2023 | 1669 | 0.740 |
Why?
|
Respiration, Artificial | 5 | 2021 | 2630 | 0.680 |
Why?
|
Drug Tolerance | 2 | 2018 | 367 | 0.680 |
Why?
|
Antiviral Agents | 6 | 2022 | 3039 | 0.650 |
Why?
|
International Classification of Diseases | 2 | 2022 | 909 | 0.630 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2018 | 2518 | 0.610 |
Why?
|
Ventilators, Mechanical | 2 | 2021 | 288 | 0.600 |
Why?
|
Massachusetts | 17 | 2024 | 8833 | 0.580 |
Why?
|
Drug Utilization Review | 1 | 2018 | 248 | 0.570 |
Why?
|
Drug Labeling | 1 | 2019 | 248 | 0.560 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 120 | 0.550 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 349 | 0.550 |
Why?
|
Oseltamivir | 3 | 2022 | 75 | 0.520 |
Why?
|
Information Storage and Retrieval | 2 | 2020 | 819 | 0.510 |
Why?
|
Drug Monitoring | 2 | 2019 | 960 | 0.510 |
Why?
|
Fentanyl | 1 | 2018 | 433 | 0.500 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 494 | 0.490 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 763 | 0.470 |
Why?
|
Denmark | 4 | 2021 | 770 | 0.470 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1374 | 0.460 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1372 | 0.440 |
Why?
|
Inappropriate Prescribing | 4 | 2024 | 202 | 0.440 |
Why?
|
Insurance, Health | 3 | 2020 | 2495 | 0.440 |
Why?
|
Medication Errors | 1 | 2019 | 783 | 0.430 |
Why?
|
Anticoagulants | 5 | 2022 | 4785 | 0.420 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1303 | 0.420 |
Why?
|
Clinical Protocols | 1 | 2018 | 1437 | 0.420 |
Why?
|
Sentinel Surveillance | 5 | 2023 | 291 | 0.410 |
Why?
|
Chlamydia Infections | 3 | 2021 | 365 | 0.410 |
Why?
|
Hospitalization | 7 | 2022 | 10704 | 0.400 |
Why?
|
United States | 30 | 2024 | 72272 | 0.400 |
Why?
|
Thrombosis | 2 | 2022 | 2943 | 0.390 |
Why?
|
Prisons | 1 | 2014 | 174 | 0.390 |
Why?
|
Population Surveillance | 8 | 2024 | 2595 | 0.370 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7402 | 0.360 |
Why?
|
Outpatients | 1 | 2018 | 1596 | 0.350 |
Why?
|
Intensive Care Units | 3 | 2021 | 3742 | 0.350 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 5031 | 0.350 |
Why?
|
Pneumonia | 1 | 2022 | 2143 | 0.350 |
Why?
|
Electronics | 2 | 2022 | 316 | 0.350 |
Why?
|
Hepatitis C | 3 | 2015 | 1579 | 0.340 |
Why?
|
Tuberculosis | 1 | 2022 | 2015 | 0.340 |
Why?
|
Humans | 68 | 2024 | 760617 | 0.320 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2568 | 0.320 |
Why?
|
Dementia | 2 | 2024 | 2680 | 0.300 |
Why?
|
HIV Infections | 5 | 2024 | 17337 | 0.300 |
Why?
|
Medicare | 2 | 2023 | 6765 | 0.300 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11459 | 0.290 |
Why?
|
Parkinson Disease | 1 | 2021 | 2878 | 0.290 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2745 | 0.290 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2896 | 0.280 |
Why?
|
Pandemics | 5 | 2024 | 8645 | 0.280 |
Why?
|
Child, Preschool | 12 | 2024 | 42188 | 0.270 |
Why?
|
Databases, Factual | 6 | 2022 | 7960 | 0.270 |
Why?
|
Adolescent | 21 | 2024 | 88234 | 0.270 |
Why?
|
Gonorrhea | 2 | 2021 | 346 | 0.270 |
Why?
|
Infant, Newborn | 9 | 2019 | 26180 | 0.260 |
Why?
|
Thromboembolism | 2 | 2022 | 991 | 0.260 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3805 | 0.250 |
Why?
|
Infant | 12 | 2020 | 36152 | 0.230 |
Why?
|
Aged | 21 | 2024 | 169042 | 0.220 |
Why?
|
Military Personnel | 1 | 2013 | 1245 | 0.220 |
Why?
|
Child | 15 | 2024 | 80079 | 0.220 |
Why?
|
Young Adult | 16 | 2024 | 59179 | 0.220 |
Why?
|
Pain | 1 | 2018 | 5061 | 0.220 |
Why?
|
Disease Notification | 2 | 2022 | 94 | 0.220 |
Why?
|
Stroke | 4 | 2022 | 9712 | 0.210 |
Why?
|
Retrospective Studies | 11 | 2024 | 80566 | 0.210 |
Why?
|
Adult | 24 | 2024 | 220969 | 0.200 |
Why?
|
Male | 30 | 2024 | 360358 | 0.200 |
Why?
|
Health Services Misuse | 2 | 2020 | 244 | 0.190 |
Why?
|
Communicable Disease Control | 2 | 2021 | 846 | 0.190 |
Why?
|
Female | 31 | 2024 | 392148 | 0.190 |
Why?
|
Middle Aged | 20 | 2024 | 220584 | 0.190 |
Why?
|
Isoniazid | 1 | 2022 | 283 | 0.180 |
Why?
|
Obesity | 2 | 2013 | 12933 | 0.180 |
Why?
|
Rifampin | 1 | 2022 | 339 | 0.180 |
Why?
|
Risk | 2 | 2022 | 9604 | 0.180 |
Why?
|
Cross Infection | 2 | 2021 | 1422 | 0.170 |
Why?
|
Dopamine Antagonists | 1 | 2021 | 288 | 0.170 |
Why?
|
Sample Size | 1 | 2023 | 838 | 0.170 |
Why?
|
Antiparkinson Agents | 1 | 2021 | 184 | 0.170 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 794 | 0.170 |
Why?
|
Zanamivir | 1 | 2018 | 21 | 0.160 |
Why?
|
Seizures, Febrile | 1 | 2020 | 108 | 0.160 |
Why?
|
Transdermal Patch | 1 | 2018 | 51 | 0.160 |
Why?
|
Quality Improvement | 4 | 2022 | 3797 | 0.160 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58894 | 0.160 |
Why?
|
Seasons | 1 | 2024 | 1518 | 0.150 |
Why?
|
Virus Diseases | 1 | 2024 | 718 | 0.150 |
Why?
|
Syphilis | 1 | 2021 | 243 | 0.150 |
Why?
|
Incidence | 4 | 2022 | 21337 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2567 | 0.150 |
Why?
|
Delayed-Action Preparations | 2 | 2018 | 962 | 0.150 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8601 | 0.150 |
Why?
|
Off-Label Use | 1 | 2019 | 185 | 0.150 |
Why?
|
Patient Dropouts | 1 | 2019 | 410 | 0.130 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 712 | 0.130 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1086 | 0.130 |
Why?
|
Health Plan Implementation | 1 | 2019 | 335 | 0.130 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2017 | 209 | 0.130 |
Why?
|
Pneumococcal Vaccines | 1 | 2020 | 397 | 0.130 |
Why?
|
Case-Control Studies | 3 | 2021 | 22148 | 0.130 |
Why?
|
Prescriptions | 1 | 2018 | 385 | 0.130 |
Why?
|
Contraception | 1 | 2019 | 347 | 0.130 |
Why?
|
Anti-Asthmatic Agents | 1 | 2020 | 574 | 0.120 |
Why?
|
Whooping Cough | 1 | 2015 | 86 | 0.120 |
Why?
|
Quinolines | 1 | 2020 | 764 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2021 | 661 | 0.120 |
Why?
|
Hepatitis C Antibodies | 1 | 2014 | 146 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.120 |
Why?
|
Drug Interactions | 1 | 2019 | 1415 | 0.120 |
Why?
|
Hospital Mortality | 3 | 2018 | 5293 | 0.110 |
Why?
|
Uterus | 1 | 2018 | 649 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2016 | 407 | 0.110 |
Why?
|
Risk Factors | 7 | 2022 | 74115 | 0.110 |
Why?
|
Inpatients | 2 | 2024 | 2544 | 0.110 |
Why?
|
Patient Care | 1 | 2019 | 621 | 0.110 |
Why?
|
Cost of Illness | 1 | 2023 | 1935 | 0.110 |
Why?
|
Oxygen | 2 | 2024 | 4226 | 0.110 |
Why?
|
Local Government | 1 | 2014 | 81 | 0.110 |
Why?
|
Odds Ratio | 2 | 2017 | 9643 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1230 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5332 | 0.100 |
Why?
|
Risk Assessment | 4 | 2022 | 23972 | 0.100 |
Why?
|
AIDS Serodiagnosis | 1 | 2014 | 219 | 0.100 |
Why?
|
Influenza Vaccines | 1 | 2020 | 767 | 0.100 |
Why?
|
Case Management | 1 | 2014 | 272 | 0.100 |
Why?
|
Health Policy | 2 | 2022 | 2682 | 0.100 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2014 | 330 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3418 | 0.100 |
Why?
|
Cohort Studies | 5 | 2021 | 41457 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1808 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1066 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1116 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2350 | 0.100 |
Why?
|
Hospitals | 3 | 2023 | 3877 | 0.090 |
Why?
|
Pregnancy | 5 | 2019 | 29868 | 0.090 |
Why?
|
Mumps virus | 1 | 2010 | 23 | 0.090 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1017 | 0.090 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2010 | 123 | 0.090 |
Why?
|
Warfarin | 1 | 2019 | 1477 | 0.090 |
Why?
|
Prisoners | 1 | 2014 | 314 | 0.090 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2010 | 71 | 0.090 |
Why?
|
Mumps | 1 | 2010 | 71 | 0.090 |
Why?
|
Polypharmacy | 2 | 2024 | 286 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2764 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2013 | 2149 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2688 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5239 | 0.080 |
Why?
|
Body Mass Index | 3 | 2022 | 12943 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2768 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2925 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10199 | 0.070 |
Why?
|
Medication Adherence | 1 | 2019 | 2174 | 0.070 |
Why?
|
Chronic Disease | 2 | 2023 | 9311 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5424 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2190 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2249 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6346 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 871 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13245 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8618 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3244 | 0.060 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 167 | 0.060 |
Why?
|
Prevalence | 4 | 2023 | 15689 | 0.060 |
Why?
|
Length of Stay | 1 | 2016 | 6418 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12447 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4764 | 0.050 |
Why?
|
Asthma | 1 | 2020 | 6233 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2009 | 1748 | 0.040 |
Why?
|
Sulfides | 1 | 2020 | 169 | 0.040 |
Why?
|
Comorbidity | 3 | 2022 | 10505 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2010 | 3150 | 0.040 |
Why?
|
Public Health | 2 | 2023 | 2669 | 0.040 |
Why?
|
Pharmacy | 1 | 2021 | 91 | 0.040 |
Why?
|
Acetates | 1 | 2020 | 321 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2020 | 432 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1248 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 2020 | 328 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1565 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10073 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 176 | 0.040 |
Why?
|
Diuretics | 1 | 2021 | 611 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2021 | 694 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2010 | 4745 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8207 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 1178 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 3800 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2315 | 0.030 |
Why?
|
Sexual Partners | 1 | 2019 | 800 | 0.030 |
Why?
|
HIV | 1 | 2020 | 1579 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2326 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2020 | 1333 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1400 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4010 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26049 | 0.020 |
Why?
|
Caregivers | 1 | 2024 | 2241 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2024 | 3066 | 0.020 |
Why?
|
Rubella virus | 1 | 2010 | 11 | 0.020 |
Why?
|
Antibody-Producing Cells | 1 | 2010 | 140 | 0.020 |
Why?
|
Research | 1 | 2019 | 1977 | 0.020 |
Why?
|
Measles virus | 1 | 2010 | 67 | 0.020 |
Why?
|
Rubella | 1 | 2010 | 55 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6305 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54360 | 0.020 |
Why?
|
Geography | 1 | 2011 | 652 | 0.020 |
Why?
|
Measles | 1 | 2010 | 181 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3251 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2643 | 0.020 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3194 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2871 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7237 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4007 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2010 | 1355 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3090 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15251 | 0.010 |
Why?
|
Vaccination | 1 | 2010 | 3370 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39913 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64568 | 0.010 |
Why?
|